Tertiary Nav - Press Releases Press ReleasesMedia Statements Press Releases Items Per Page 102550 News Category Business & FinancialCitizenshipEarningsMedia StatementProduct NewsRecognitionRegulatoryScience & Innovation Year None202320222021202020192018201720162015201420132012201120102009200820072006 Date Title 6/2/22 Sarepta Therapeutics to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference 5/31/22 Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 5/5/22 Sarepta Therapeutics Launches Inaugural LGMD Grant Award Program 5/5/22 Sarepta Therapeutics lanza el programa inaugural de concesión de subvenciones para la LGMD 5/4/22 Sarepta Therapeutics Announces First Quarter 2022 Financial Results and Recent Corporate Developments 5/4/22 Sarepta Therapeutics to Present at the BofA Securities 2022 Healthcare Conference 4/29/22 Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 4/27/22 Sarepta Therapeutics to Announce First Quarter 2022 Financial Results and Recent Corporate Developments on May 4, 2022 3/31/22 Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 3/8/22 Sarepta Therapeutics Announces Fifth Year of Route 79, The Duchenne Scholarship Program Pagination First page « first Previous page ‹ previous … Page 3 Page 4 Page 5 Page 6 Current page 7 Page 8 Page 9 Page 10 Page 11 … Next page next › Last page last » Displaying 61 - 70 of 788 Toolkit Print Page | Email Alerts | RSS Feeds | Contacts
Press Releases Items Per Page 102550 News Category Business & FinancialCitizenshipEarningsMedia StatementProduct NewsRecognitionRegulatoryScience & Innovation Year None202320222021202020192018201720162015201420132012201120102009200820072006 Date Title 6/2/22 Sarepta Therapeutics to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference 5/31/22 Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 5/5/22 Sarepta Therapeutics Launches Inaugural LGMD Grant Award Program 5/5/22 Sarepta Therapeutics lanza el programa inaugural de concesión de subvenciones para la LGMD 5/4/22 Sarepta Therapeutics Announces First Quarter 2022 Financial Results and Recent Corporate Developments 5/4/22 Sarepta Therapeutics to Present at the BofA Securities 2022 Healthcare Conference 4/29/22 Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 4/27/22 Sarepta Therapeutics to Announce First Quarter 2022 Financial Results and Recent Corporate Developments on May 4, 2022 3/31/22 Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 3/8/22 Sarepta Therapeutics Announces Fifth Year of Route 79, The Duchenne Scholarship Program Pagination First page « first Previous page ‹ previous … Page 3 Page 4 Page 5 Page 6 Current page 7 Page 8 Page 9 Page 10 Page 11 … Next page next › Last page last » Displaying 61 - 70 of 788